|Articles|March 1, 2001
- Pharmaceutical Executive-03-01-2001
- Volume 0
- Issue 0
Lilly's International Family
Author(s)L.J. Sellers
Sidney Taurel Takes His Global Team Beyond Prozac
Advertisement
Articles in this issue
over 24 years ago
Research: New Horizonsover 24 years ago
Earnings: Tough Times Aheadover 24 years ago
Outbreak: Anthrax Alarmover 24 years ago
Patents: China on the Genome Mapover 24 years ago
Privacy, Pediatrics, and Policyover 24 years ago
Update: Punishment and Reprieveover 24 years ago
Shortage: Vaccine Worriesover 24 years ago
Gateway to Japanover 24 years ago
SurroundedNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
2
Could DTC Programs Help Simplify the Drug-Pricing System?
3
Lilly Enters Definitive Agreement Acquiring Aderum Biotechnologies
4
AI Becomes Pharma’s New Operating System: Q&A with causaLens’ CEO and Co-Founder Darko Matovski
5
